Acular LS (Ketorolac Tromethamine Ophthalmic) - Summary

ACULAR LS SUMMARY

ACULAR LS™
(ketorolac tromethamine ophthalmic solution) 0.4%

ACULAR LS™ (ketorolac tromethamine ophthalmic solution) 0.4% is a member of the pyrrolo-pyrrole group of nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use.

ACULAR LS™ ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

ACULAR LS NEWS HIGHLIGHTS

Published Studies Related to Acular LS (Ketorolac Ophthalmic)

Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]

Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]

In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. [2007.09]

Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification. [2007.07]

Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. [2006.09]

more>>

Clinical Trials Related to Acular LS (Ketorolac Ophthalmic)

Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity [Enrolling by invitation]

Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery [Completed]

Topical 0.4% Ketorolac and Vitreoretinal Surgery [Completed]

Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-Operative Cystoid Macular Edema. [Active, not recruiting]

Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK [Completed]

more>>